[Mobile multiple left chamber thrombi causing multiple embolism in the limbs requiring surgery].

Orv Hetil

Heves Megyei Onkormányzat Markhot Ferenc Kórház-Rendelöintézet, Eger, I. Belgyógyászati Osztály, Kardiológia.

Published: February 1995

The authors report on the case of a 35-year-old man with multiple risk factors, who was sent to cardiac examination in order to find the cause of microembolisms on his fingers of his hands and on his right leg. According to the history and the ECG the patient had suffered an anterior myocardial infarction at home two months before the embolisms which had not been detected at that time. Performing 2D echocardiography, wall motion abnormality indicating anterior myocardial infarction and several thrombi were found as the source of embolisms. One of the thrombi were highly mobile. During 7 week of anticoagulant therapy there was no new embolism but the thrombi did not show regression, therefore the patient was sent to the Hungarian Institute of Cardiology where successful thrombectomy and revascularisation were performed after transoesophageal echocardiography and coronarography. At two year follow-up after the surgery there was no new thrombus detected. In connection with the case the authors surveyed the literature of left ventricular thrombus formation following myocardial infarction.

Download full-text PDF

Source

Publication Analysis

Top Keywords

myocardial infarction
12
anterior myocardial
8
[mobile multiple
4
multiple left
4
left chamber
4
thrombi
4
chamber thrombi
4
thrombi causing
4
causing multiple
4
multiple embolism
4

Similar Publications

The autonomic nervous system plays a crucial role in regulating physiological processes and maintaining homeostasis through its two branches: the sympathetic nervous system (SNS) and the parasympathetic nervous system. Dysregulation of the autonomic system, characterized by increased sympathetic activity and reduced parasympathetic tone, is a common feature in chronic kidney disease (CKD) and cardiovascular disease. This imbalance contributes to a pro-inflammatory state, exacerbating disease progression and increasing the risk for cardiovascular events.

View Article and Find Full Text PDF

Introduction: The infarcted heart is energetically compromised exhibiting a deficient production of adenosine triphosphate (ATP) and the ensuing impaired contractile function. Short-term blockade of the protein S100A9 improves cardiac performance in mice after myocardial infarction (MI). The implications upon ATP production during this process are not known.

View Article and Find Full Text PDF

Rationale: The biodegradable polymer BioMatrix Alpha™ stent contains biolimus A9 drug which is sirolimus derivative increase in lipophicity. The biodegradable polymer sirolimus eluting Combo™ stent is a dual-therapy sirolimus-eluting and CD34+ antobody coated stent capturing endothelial progenitor cells (EPCs).

Hypothesis: The main hypothesis of the SORT OUT XI trial was that the biodegradable polymer biolimus A9 BioMatrix Alpha ™ stent is noninferior to the biodegradable polymer sirolimus eluting Combo™ stent in an all-comers population with coronary artery disease undergoing percutaneous coronary intervention (PCI).

View Article and Find Full Text PDF

Background: Despite the high mortality of cardiogenic shock after acute myocardial infarction (AMI-CS), the comparative efficacy and safety of mechanical circulatory support (MCS) in patients with AMI-CS is unknown. This study aimed to compare the efficacy and safety of various MCS with initial medical therapy for AMI-CS patients.

Methods: We searched PubMed and EMBASE in July 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!